BAUSCH + LOMB CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.98 USD | +0.50% |
|
+9.04% | -5.92% |
| Jul. 10 | Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target | MT |
| Jul. 08 | RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.59B | - | |||||
| 181B | ||||||
| 100B | ||||||
| 65.01B | ||||||
| 45.75B | ||||||
| 44.8B |
